Core Laboratories (CEI) Stock Statistics & Valuation Metrics

Core Laboratories has a market cap or net worth of CHF465.05M. The enterprise value is CHF694.61.

Core Laboratories has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Core Laboratories’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 6.83%.

The current PE Ratio of Core Laboratories is 22.1. Core Laboratories’s PEG ratio is 15.79.

In the last 12 months, Core Laboratories had revenue of 526.52M and earned 29.67M in profits. Earnings per share was 0.68.

In the last 12 months, operating cash flow was 28.22M and capital expenditures -17.49M, giving a free cash flow of 10.73M billion.

Core Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Core Laboratories upcoming earnings date is Oct 28, 2026, After Close (Confirmed).

Core Laboratories as a current ratio of 2.02, with Debt / Equity ratio of 60.56%

In the past 12 months, Core Laboratories has paid 15.51M in taxes.

Core Laboratories EV to EBITDA ratio is 12.47, with an EV/FCF ratio of 39.78.

Core Laboratories has CHF22.73M in cash and marketable securities with CHF165.12M in debt, giving a net cash position of -CHF142.38M billion.

Gross margin is 18.12%, with operating margin of 9.59%, and net profit margin of 5.63%.

The average price target for Core Laboratories is CHF8.91, which is 11.43% higher than the current price. The consensus rating is Moderate Sell